KalVista Pharmaceuticals ... (KALV)
NASDAQ: KALV
· Real-Time Price · USD
13.04
0.08 (0.62%)
At close: Jun 16, 2025, 3:59 PM
13.33
2.26%
After-hours: Jun 16, 2025, 07:37 PM EDT
0.62% (1D)
| Bid | 11.95 |
| Market Cap | 648.04M |
| Revenue (ttm) | 1.21M |
| Net Income (ttm) | -175.87M |
| EPS (ttm) | -3.63 |
| PE Ratio (ttm) | -3.59 |
| Forward PE | -4.34 |
| Analyst | Buy |
| Ask | 15 |
| Volume | 1,578,083 |
| Avg. Volume (20D) | 597,031 |
| Open | 12.39 |
| Previous Close | 12.96 |
| Day's Range | 12.16 - 13.25 |
| 52-Week Range | 7.30 - 15.50 |
| Beta | -0.02 |
About KALV
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KALV
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for KALV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+9.49%
KalVista Pharmaceuticals shares are trading higher...
Unlock content with
Pro Subscription
6 months ago
+8.28%
KalVista Pharmaceuticals shares are trading higher. HC Wainwright & Co. reiterated a Buy rating on the stock.
